The independent source for health policy research, polling, and news.
17,441 - 17,460 of 112,659 Results
The report from Reuters says that the lower price reflects the financial support given by the European Union to BioNTech for the drug’s development. News is on Mexico and Serbia, as well.
A letter from more than 100 congressional Democrats calls for the women to receive necessary certifications for a chance to apply for U-visas, which allow undocumented immigrants who have assisted law enforcement to apply to stay in the country legally, The Washington Post reports.
The adult smoking rate last saw a substantial drop in 2017. The new figures mean there are more than 34 million adult smokers in the U.S. About 11 million people are e-cigarette users. News is on the pandemic's toll on smokers, a delay in the execution of a woman on death row, and more.
Miami International has the largest number of cases -- 157 -- reported. News is on ways to keep yourself safe while navigating airports, and updates on sports and celebrities.
Some or most schools except K-8 are closing in places like New York City, Kentucky and Michigan. Many are receiving political pushback over whether closures help reduce infection spread.
"MHD staff have received death threats, have actively had their identity circulated over social media in posts or comments promoting aggressive acts, and had two individuals appear at an MHD location requesting access to such MHD staff," the department said in a statement.
New research published this week suggests that combining a cancer vaccine with adjuvant molecules might help prevent the recurrence of melanoma. In AIDS developments, deaths related to HIV plunged from 2010 to 2018, data show.
In Carson City, Nevada, 470 prisoners out of 525 have tested positive at the Warm Springs Correctional Center, along with 55 staff members. News is on the Sequoia Project, Quality Payment Program and Nuance Communications.
The suggestion was contained in a proposal made three years ago by McKinsey consultants, STAT reports.
A new study found that 28% of COVID-19 patients ages 65 and older at seven U.S. emergency departments had delirium. In some cases, it was their only symptom.
The Trump administration approved a $590 million loan Thursday for the single-use, self-contained devices that are designed to be an alternative to traditional vials and syringes.
In other news on COVID treatments, the FDA on Thursday authorized the emergency use of baricitinib, a drug made by Eli Lilly. When used with remdesivir, the drug can reduce recovery time from COVID-19.
The Biden team continues to plan for its coronavirus crisis response, though President-elect Joe Biden said Thursday: “Unfortunately, my administration hasn’t been able to get everything we need" with the ongoing transition delay.
Treasury Secretary Steven Mnuchin says the pandemic relief program is no longer needed. The Federal Reserve opposed the move.
The "most favored nation” rule would tie what Medicare pays for prescription drugs to costs paid by other wealthy countries. The other regulation will limit rebates paid to pharmacy benefit managers. It's unclear if the Biden administration will roll back the rules, which the pharmaceutical industry opposes.
Urging vigilance until a mass vaccine program is in place, members of the White House coronavirus task force held its first press briefing since July.
As state and local leaders renew or add restrictions to try to contain the coronavirus spread, an analysis finds that the states with the least strict measures in place over the summer and early fall are now experiencing the worst outbreaks.
For the first time since May, daily coronavirus deaths passed 2,000 in the U.S. on Thursday, with no end in site as cases of new infections continue to also break records.
A week ahead of the holiday, CDC issued guidance stating: "Postponing travel and staying home is the best way to protect yourself and others this year." The agency also urged celebrating with just immediate household members.
Pfizer and its partner BioNtech will be the first to file for FDA review of its coronavirus vaccine -- an evaluation that is expected to take several weeks.
© 2026 KFF